Positive recommendation moves Januvia closer to Japanese market
27 July 2009
Ian Haydock
Please Login to read the full article.
27 July 2009
Ian Haydock
Banyu/ Merck & Co's Januvia (sitagliptin) has become the first DPP-4 inhibitor to be recommended for approval in Japan following a positive opinion from a review committee of the ministry of health, labour and welfare.
The first-in-class product remains subject to further review...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
